p16/MTS1/INK4A suppresses prostate cancer by both pRb dependent and independent pathways

Oncogene

Volumn 19, Issue 10, 2000, Pages 1297-1306

  Steiner, Mitchell S ^a   Wang, Ying ^a   Zhang, Yu ^a   Zhang, Xiongwen ^a   Lu, Yi ^a,b  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

Author keywords

Adenovirus; Demethylation; p16; pRb; Senescence

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; BETA GALACTOSIDASE; PROTEIN P16; RETINOBLASTOMA PROTEIN;

ADENOVIRUS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL AGING; CELL PROLIFERATION; CONTROLLED STUDY; EXPRESSION VECTOR; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROSTATE CANCER; TUMOR SUPPRESSOR GENE;

ADENOVIRIDAE;

EID: 0034594951     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1203428     Document Type: Article

References (74)

1. Arap W, Nishikawa R, Furnari FB, Cavenee WK and Huang HJ. (1995). Cancer Res., 55, 1351-1354.
2. Bates S, Bonetta L, Macallan D, Parry D, Holder A, Dickson C and Peters G. (1994). Oncogene, 9, 71-79.
3. Banerjee A, Xu HJ, Hu SX, Araujo D, Takahashi R, Stanbridge EJ and Benedict WF. (1992). Cancer Res., 52, 6297-6304.
4. Bookstein R, Shew JY, Chen PL, Scully P and Lee WH. (1990). Science, 24, 712-715.
5. Cairns P, Polascik TJ, Eby Y and Sidransky D. (1995). Nature Genet., 11, 210-212.
6. Caldas C, Hahn SA, De Costa LT, Redston MS, Schutte M, Seymour AB, Weistein CL, Hruban RH, Yeo CJ and Kern SE. (1994). Nature Genet., 8, 27-32.
7. Chen Z-H, Zhang H and Savarese T. (1996). Cancer Res., 56, 1083-1090.
8. Craig C, Kim M, Ohri E, Wersto R, Katayose D, Li Z, Choi Y, Mudahar B, Srivastava S, Seth P and Cowan K. (1998). Oncogene, 16, 265-272.
9. Dimri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C, Medrano EE, Linskens M, Rubelj I and Pereira-Smith O. (1995). Proc. Natl. Acad. Sci. USA, 92, 9363-9367.
10. Fairweather DS, Fox M and Margison GP. (1987). Exp. Cell Res., 168, 153-159.
11. Foulkes WD, Flanders TY, Pollock PM and Hayward NK. (1997). Mol. Med., 3, 5-20.
12. Fueyo J, Gomez-Manzano C, Yung WK, Clayman GL, Liu TJ, Bruner J, Levin VA and Kyritsis AP. (1996). Oncogene, 12, 103-110.
13. Geradts J and Wilson PA. (1996). Am. J. Path., 149, 15-20.
14. Gotoh A, Kao C, Ko S-C, Hamada K, Liu T-J and Chung LWK. (1997). J. Urol., 158, 636-641.
15. Graham FL and Prevee L. (1991). Methods in Molecular Biology. Murray EJ. (ed.). Human Press Inc, Chapter 11, pp. 109-128.
16. Guan KL, Jenkins CW, Li Y, Nichols MA, Wu X, O'keefe CL, Matera AG and Xiong Y. (1994). Genes. Dev., 8, 2923-2952.
17. Haas K, Staller P, Geisen C, Bartek J, Eilers M and Moroy T. (1997). Oncogene, 15, 179-192.
18. Hama S, Sadatomo T, Yoshioka H, Kurisu K, Tahara E, Naruse I, Heike Y and Saijo N. (1997). Anticancer Res., 17, 1933-1938.
19. Hara E, Smith R, Parry D, Tahara H, Stone S and Peters G. (1996). Mol. Cell. Biol., 16, 859-867.
20. Hatta Y, Hirama T, Miller CW, Tomonaga M and Koeffler HP. (1995). Blood, 85, 2699-2704.
21. Herman JG, Jen J, Merlo A and Baylin SB. (1996). Cancer Res., 56, 722-727.
22. Holliday R. (1986). Exp. Cell Res., 166, 543-552.
23. Hussussian CJ, Struewing JP, Goldstein AM, Higgins PAT, Ally DS, Sheahan MD, Clark WH, Tucker MA and Dracopoli NC. (1994). Nature Genet., 8, 15-21.
24. Itoh N, Kakehi Y, Akao T, Kinoshita H, Okada Y and Yoshida O. (1997). Jpn. J. Cancer Res., 88, 229-233.
25. Jarrard DF, Bova GS, Ewing CM, Pin SS, Nguyen SH, Baylin SB, Cairns P, Sidransky D, Herman JG and Isaacs WB. (1997). Genes Chromosomes Cancer, 19, 90-96.
26. Jarrard DF, Sarkar S, Shi Y, Yeager TR, Magrane G, Kinoshita H, Nassif N, Meisner L, Newton MA, Waldman FM and Reznikoff CA. (1999). Cancer Res., 59, 2957-2964.
27. Jen J, Harper JW, Bigner SH, Bigner DD, Papadopoulos N, Markowitz S, Willson JKV, Kinzler KW and Vogelstein B. (1994). Cancer Res., 54, 6353-6358.
28. Kratzke R, Otterson GA, Lincoln CE, Ewing S, Oie H, Geradts J and Kaye FJ. (1995). J. Natl. Cancer Inst., 87, 1870-1875.
29. Kratzke RA, Greatens JM, Rubins JB, Maddaus MA, Niewoehner DE, Niehans GA and Geradts J. (1996). Cancer Res., 56, 3415-3420.
30. Li YJ, Hoang-Xuan K, Delattre JY, Poisson M, Thomas G and Hamelin R. (1995). Oncogene, 11, 597-600.
31. Liggett WH and Sidransky D. (1998). J. Clin. Oncol., 16, 1197-1206.
32. Liu Q, Neuhausen S, Mcclure M, Frye C, Weaver-Feldhaus J, Gruis NA, Eddington K, Allalunis-Turner MJ, Skolnick MH, Fujimura FK and Kamb A. (1995). Oncogene, 10, 1061-1067.
33. Loughran O, Malliri A, Owens D, Gallimore PH, Stanley MA, Ozanne B, Frame MC and Parkinson EK. (1996). Oncogene, 13, 561-568.
34. Lu Y, Whitaker L, Li X, Lotan D and Lotan R. (1995). Mol. Cell. Differ., 3, 175-191.
35. Lu Y, Zhang Y and Steiner MS. (1998a). DNA Cell Biol., 17, 643-645.
36. Lu Y, Amos B, Cruise E, Lotan D and Lotan R. (1998b). Biol. Chem., 379, 1323-1330.
37. Lu Y, Carraher J, Zhang Y, Armstrong J, Lerner J, Roger W and Steiner MS. (1999). Cancer Gene Ther., 6, 64-72.
38. Lukas J, Parry D, Aagaard L, Mann DJ, Bartkova J, Strauss M, Peters G and Bartek J. (1995). Nature, 375, 503-506.
39. Mao L, Merlo A, Bedi G, Shapiro GI, Edwards CD, Rollins BJ and Sidransky D. (1995). Cancer Res., 55, 2995-2997.
40. Mobley SR, Liu TJ, Hudson JM and Clayman GL. (1998). Arch. Otolaryngol. Head Neck Surg., 124, 88-92.
41. Mori T, Miura K, Aoki T, Nishihira T, Mori S and Nakamura Y. (1994). Cancer Res., 54, 3396-3397.
42. Nobori T, Miura K, Wu DJ, Lois A, Takabayashi K and Carson DA. (1994). Nature, 368, 753-756.
43. Norbury C and Nurse P. (1992). Annu. Rev. Biochem., 61, 441-470.
44. Okamoto A, Demetrick DJ, Spillane EA, Hagiwara K, Hussain SP, Bennett WH, Forrester K, Gerwin B, Serrano M, Beach DH and Harris CC. (1994). Proc. Natl. Acad. Sci. USA, 91, 11045-11049.
45. Orlew I, Lacombe L, Hannon GJ, Serrano M, Pellicer I, Dalbagni G, Reuter VE, Zhang Z-F, Beach D and Cordon-Cardo C. (1995). J. Intl. Cancer Inst., 87, 1524-1529.
46. Palmero I, McConnell B, Parry D, Brookes S, Hara E, Bates S, Jat P and Peters G. (1997). Oncogene, 15, 495-503.
47. Park M and Koff A. (1998). Current Protocols in Cell Biology. Bonifacino JS, Dasso M, Harford JB, Lippincott-Schwartz J and Yamada KM. (eds). John Wiley & Sons, Inc., Chapter 8, pp. 8.3.1-8.3.16.
48. Quesnel B, Preudhomme C, Lepelley P, Hetuin D, Vanrumbeke M, Bauters F, Velu T and Fenaux P. (1996). Br. J. Hematol., 95, 291-298.
49. Reznikoff CA, Yeager TR, Belair CD, Savelieva E, Puthenveettil JA and Stadler WM. (1996). Cancer Res., 56, 2886-2890.
50. Sandig V, Brand K, Herwig S, Lukas J, Barlek J and Strauss M. (1997). Nature Med., 3, 313-319.
51. Sarkar FH, Sakr W, Li YW, et al. (1992). Prostate, 21, 145-152.
52. Schrump DS, Chen GA, Consuli U, Jin X and Roth JA. (1996). Cancer Gene Ther., 3, 357-364.
53. Serrano M, Hannon GJ and Beach D. (1993). Nature, 366, 704-707.
54. Serrano M, Gomez-Lahoz E, De Pinho RA, Beach D and Bar-Sagi D. (1995). Science, 267, 249-252.
55. Serrano M, Lee H, Chin L, Cordon-Cardo C, Beach D and Depinho RA. (1996). Cell, 85, 27-37.
56. Shapiro GI and Rollins BJ. (1996). Biochem. Biophys. Acta., 1242, 165-169.
57. Sherr CJ. (1993). Cell, 73, 1059-1065.
58. Smith-Sorenson B and Hovig E. (1995). Human Mutation, 7, 294-303.
59. Steiner MS and Anthony CT. (1996). Mol. Cell Differ., 4, 275-295.
60. Steiner MS, Anthony CT, Lu Y and Holt JT. (1998). Human Gene Ther., 9, 747-755.
61. Steiner MS, Zhang Y, Farooq F, Lerner J, Wang Y and Lu Y. (1999a). Cancer Gene Ther., in press.
62. Steiner MS, Zhang Y, Carraher J and Lu Y. (1999b). Cancer Gene Ther., 6, 456-464.
63. Stone S, Dayananth P and Kamb A. (1996). Cancer Res., 56, 3199-3202.
64. Takeuchi S, Bartram CR, Seriu T. Miller CW, Tobler A, Janssen JW, Reiter A, Ludwig WD, Zimmermann M, Schwaller J, et al. (1995). Blood, 86, 755-760.
65. Talve L, Sauroja I, Collan Y, Punnonen K and Ekfors T. (1997). Int. J. Cancer, 74, 255-259.
66. Uhrbom L, Nister M, Westermark B. (1997). Oncogene, 15, 505-514.
67. Vogt M, Haggblom C, Yeargin J, Christiansen-Weber T, Haas M. (1998). Cell Growth Differ., 9, 139-146.
68. Washimi O, Nagatake M, Osada H, Ueda R, Koshikawa T, Seki T, Takahashi T and Takahashi T. (1995). Cancer Res., 55, 514-517.
69. Wilson VL and Jones PA. (1983). Science, 220, 1055-1057.
70. Wolf JK, Kim TE, Fightmaster D, Bodurka D, Gershenson DM, Mills G and Wharton JT. (1999). Gynecol. Oncol., 73, 27-34.
71. Xiao S, Li D, Vijg J, Sugarbaker DJ, Corson JM and Fletcher JA. (1995a). Oncogene, 11, 511-515.
72. Xiao S, Li D, Corson JM, Vijg J and Fletcher JA. (1995b). Cancer Res., 55, 2968-2971.
73. Zhang Y, Stein R, Wang W, Steiner MS and Lu Y. (1999a). Tumor Targeting, 4, 1-12.
74. Zhang XW, Qing C and Xu B. (1999b). Anticancer Drugs, 10, 569-576.